← Eichor
Study identifier: NCT07461701 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of 15% Versus 30% Velocity Loss Thresholds During Bodyweight Squats and Their Effects on Strength and Endurance in Young Women

Condition: Lower-Limb Strength · Muscular Endurance · Velocity-Based Resistance Training  ·  Sponsor: University of Health Sciences Lahore

PhaseNA
Planned participants52
Who can joinFemale, 18 Years to 25 Years
Healthy volunteersYes

About this study

The goal of this clinical trial is to learn how two different velocity loss thresholds (15% and 30%) during bodyweight squats affect strength and endurance in non-athletic young women aged 18-25 years. The main questions it aims to answer are: Does a lower velocity loss threshold (15%) during bodyweight squats improve lower-limb strength? Does a higher velocity loss threshold (30%) during bodyweight squats improve muscular endurance? Researchers will compare the two groups (15% vs. 30% velocity loss) to see if one approach works better for strength and endurance. Participants will: Perform bodyweight squats three times per week for six weeks. Be randomly assigned to either the 15% or 30% velocity loss group. Complete strength and endurance tests before and after the program

This description comes directly from the study's public registry record.

Talk to the study team

Shiza Maryam, Doctor of Physical Therapy  ·  +92 333 8813397  ·  shiza.maryam.pk@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University of Health SciencesLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07461701